Not Yet RecruitingNCT07503002
Shortened LSD Intervention for Major Depressive Disorder
This study isn't recruiting yet.
In BaltimoreDepressionMedication studyAges 21–70
Study directory
Back to overviewDepression studies
Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.
Not Yet RecruitingNCT07479550
Psilocybin Under Anesthesia Controlled by EEG
Official study title
A Phase 2 Randomized Study Examining the Safety, Feasibility, and Effectiveness of Masking Psilocybin Therapy With General Anesthesia in Major Depressive Disorder
This study isn't recruiting yet.
In StanfordDepressionMedication studyAges 25–65
RecruitingACTRN12623001080617
An Open Label Safety and Efficacy Study of XW10508 Modified Release (MR) in people with Major Depressive Disorder
Official study title
In AdelaideA Phase 2 Open Label Pilot Study of XW10508 Modified Release Tablets Assessing Safety and Efficacy in Patients with Major Depressive Disorder
DepressionInterventional studyAges 18–70
RecruitingACTRN12624000040561
Effectiveness of Psychedelic Therapy for Treatment Resistant Depression (TRD)
In AustraliaDepressionInterventional studyAges 18–65
RecruitingISRCTN14516822
Home-based transcranial direct current stimulation for major depressive disorder
In United KingdomDepressionResearch studyAges 18–100
RecruitingACTRN12621000498897
Novel transcranial electrical modulation for Major Depressive Disorder
Official study title
In New ZealandNovel high-definition transcranial grey noise stimulation (HD-tGNS) for the treatment of Major Depressive Disorder: A proof of concept study
DepressionInterventional studyAges 18–60
RecruitingACTRN12623001068651
Positioning of Esketamine Treatment (PoET) in the real-world management of depression
Official study title
In St LeonardsEvaluating the Positioning of Esketamine Treatment (PoET) for symptom management in adults with major depressive disorder
DepressionInterventional studyAges 18–65
RecruitingACTRN12617000400369
PRT MEDIC: Progressive Resistance Training for MEtabolic Syndrome and Depression Integrated Care
Official study title
In AustraliaEffect of Progressive Resistance Training on insulin resistance and depression in adults with Metabolic Syndrome and Major Depressive Disorder.
DepressionInterventional studyAges 40+
RecruitingACTRN12615000566538
Studying the antidepressant effects of intravenous ketamine in people with major depressive disorder
Official study title
In SingaporeStudying the antidepressant effects of intravenous ketamine in patients with major depressive disorder
DepressionInterventional studyAges 21–65
Not Yet RecruitingACTRN12621000115831
Effectiveness of Probiotics as an additional treatment in Major depressive Disorder in community: Study
Official study title
Effectiveness of multistrain probiotics as an adjuvant treatment in Major Depressive Disorder in community: A Pilot study
This study isn't recruiting yet.
In New ZealandDepressionInterventional studyAges 18–65
Not Yet RecruitingACTRN12626000122358
Evaluating the effect of a reminiscence-based therapy focused on social memories and future social experiences on social connectedness for depression
Official study title
A single-case evaluation of a social reminiscence-based intervention targeting social autobiographical memory and social episodic future thinking on perceived social connectedness in adults with major depressive disorder
This study isn't recruiting yet.
In AustraliaDepressionInterventional studyAges 18+
Not Yet RecruitingACTRN12626000316303
PANDA: Psilocybin-assisted therapy for treatment of Addiction and comorbid depression
Official study title
PANDA: An Open Label Pilot Study of Single-Dose Psilocybin-Assisted Therapy for the Treatment of Alcohol Use Disorder with Comorbid Major Depressive Disorder in routine Alcohol and Other Drugs practice
This study isn't recruiting yet.
In AustraliaDepression, AddictionInterventional studyAges 18+
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.